Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), announced that physician demand continues to build throughout the United States for its recently approved Diamondback 360(R) Coronary Orbital Atherectomy System (OAS). The system is the first and only technology approved for the treatment of severely calcified coronary lesions, and the only new FDA-approved coronary atherectomy device in more than two decades. Said Dr. Rohit Bhatheja, Interventional Cardiologist, Florida Hospital Orlando, a physician who recently treated his first case with the Diamondback 360 Coronary OAS: Calcium in coronary arteries often goes undetected and even more, is left untreated because of its complexity. CSIs OAS enables physicians to easily treat severely calcified vessels, and allows for successful stent deployment.
Posted on: Fri, 24 Jan 2014 13:48:33 +0000
Trending Topics
Recently Viewed Topics
© 2015